# CJC-1295 hormone findings leave lasting health benefits unproven > CJC-1295 — Research Peptide Fundamentals research peptides — Research Peptide Fundamentals research peptides: early CJC-1295 studies found higher hormones. That finding leaves lasting benefits and safety unanswered. **01 / HIGHER HORMONES / LIMITED HUMAN TESTING** What did these early tests show in people? Hormones stayed higher for days. Those readings don’t prove that you recover better or stay healthier. ## The short version: hormone rises leave recovery claims unanswered Did people become healthier in the early CJC-1295 studies? The tests showed higher hormones, while the usual bursts continued [4][5]. Better health and healthier aging were not proved by those tests. Better recovery and useful fat loss remain separate, unanswered questions. Early testing covered only a small part of the safety questions. Higher blood readings cannot stand for benefits that weren't measured. Growth hormone is made by the pituitary gland, just under the brain. CJC-1295 prompts that gland to release extra growth hormone into blood. Growth hormone helps keep tissues working and supports growth. Changes to CJC-1295 protect the substance from being broken down. One version joins albumin, a protein found in your blood. That protein attachment helps the version called DAC last longer. The version without DAC acts for a much shorter time. One version's findings don't apply to the other without further testing. Neither careful chemical design nor lasting action shows a safe treatment. Human health benefits need studies that measure those benefits directly. ## DAC names the version that attaches to blood protein CJC-1295 copies the first 29 amino acids from a natural hormone; these small chemical pieces also form proteins. Four changes make those joined pieces harder to break apart. An extra part joins the lasting version to a protein in blood. That protein is albumin, which carries the joined substance through blood. Staying attached delays the substance leaving blood. The shared name can conceal an important difference for you. **CJC-1295 with DAC** is the version with that albumin attachment. **CJC-1295 without DAC** lacks the attachment and acts more briefly. Both versions have changes that help protect them against breakdown. Animal and laboratory tests linked the attachment to longer action [7]. Tests identified CJC-1295 in a product seized during a sports-drug investigation [2]. The investigators checked the contents rather than relying on the label. A finding with the attached version cannot prove the unattached version's effects. A bottle's name alone cannot settle which version is inside. ## A growth-hormone rise prompts another hormone from the liver The liver and other tissues respond to growth hormone by making a second hormone. The second hormone, insulin-like growth factor 1, supports growth within tissues. The substance being studied starts this process by prompting extra growth-hormone release. Researchers can then measure both hormones in blood after treatment. The measurements show an effect, without showing a useful health benefit. Your recovery is a different question from your hormone reading. Protective changes slow the usual breakdown of the tested substance. The longer-lasting version also stays attached to albumin in blood. That blood protein carries the attached substance along with it. Rat tests found growth hormone staying higher with the attachment [7]. Laboratory tests also examined how the attachment protected against breakdown. A review discussed attempts to make these hormone effects last longer [1]. The review discussed existing treatments alongside substances still being studied. Discussing those possibilities does not show that CJC-1295 improved patients' health. Longer patient comparisons still need to measure lasting benefits alongside harm. ## Healthy adults had hormones staying higher after study shots Shots given to healthy adults caused lasting blood-hormone rises [4]. Growth hormone stayed above the earlier readings for at least six days. Insulin-like growth factor remained higher across nine to eleven days. Larger shots produced larger average rises in those blood readings. After repeated shots, the second hormone stayed higher for up to 28 days. That finding concerns the period following the repeated study shots. The test describes measured effects, not a plan for your care. Lasting health benefits remained a question for later studies. Another study checked healthy men one week after study treatment. Average growth hormone rose about 46%; insulin-like growth factor rose about 45% [5]. Growth hormone also rose between the body's usual release bursts. The bursts themselves remained much the same size and frequency. A separate test found blood-protein changes in 11 healthy men [3]. Some protein changes were linked with the second hormone's level. These blood tests didn't settle questions about lasting benefits or harm. Mice lacking the natural hormone that triggers growth grew better with treatment. Daily treatment restored growth better than treatment spaced farther apart [6]. The growth finding concerns mice, not recovery in injured people. Rat and laboratory tests compared the attached and unattached substances. Over the brief test period, total growth hormone measured was four times as great when the attachment was present. The attached peptide could still be detected beyond 72 hours [7]. That version also resisted breakdown better than the unattached version. These tests concerned mice, rats, and laboratory material, not human healing. Early human work largely measured hormones instead of lasting health changes. ## Sleep reports also describe swelling and other possible harms **These reports describe attempts with the substance outside trials, for research. Doctor involvement isn't clear. Studies comparing treatment groups haven't checked these accounts.** Deeper sleep and water building up as swelling appear very often. Less soreness, quicker recovery, and slowly losing fat are often mentioned too. Some report looking leaner, tingling in their hands, or discomfort following shots. Other reports mention changes in energy, focus, appetite, or blood sugar. Headache and tiredness appear too, along with flushing: sudden warm, red skin. Other treatments and hopes of improvement can affect these reports. Those experiences cannot show that CJC-1295 caused the reported changes. Small human studies mainly measured hormone changes over short periods [3][4][5]. Early tests clearly found growth-related hormones rising in blood [4][5]. Those rises don't show better recovery or a longer life. Your question needs a trial measuring the benefit being claimed. The attached version lasts longer, which also changes safety questions. Tests identified substances outside formal studies and examined protein attachment [2][7]. This research describes CJC-1295 without any approved treatment use for people. The substance is prohibited where sports drug tests check for banned substances. Those are drug tests, not tests of fitness to play. Missing large trials leave uncommon and long-term harms uncertain. ## The patient evidence is smaller than for approved medicines Studies explain why the attached CJC-1295 version lasts for days. Albumin carries that version in blood and helps protect against breakdown [7]. The chemical result is clearer than the evidence for improved health. Later studies would still need to show benefits and long-term safety. Lasting hormone activity alone cannot judge your health. A result for the attached version also cannot cover both versions. [Tesamorelin](/tesamorelin) prompts the same hormone system but has a narrow approved use. Its trials measured unusual belly-fat storage in people treated for HIV. [Semaglutide](/semaglutide) has much larger studies of actual changes in patients' health. [BPC-157](/bpc-157) has less human testing of its proposed repair effects. Those comparisons concern the people tested, not the cleverness of a chemical design. Early CJC-1295 studies showed hormone rises rather than lasting health gains. The smaller study history also leaves uncommon harms harder to judge. The measured effect therefore belongs beside those unanswered health questions. ![CJC-1295 research illustration](/images/cjc-1295.webp) --- True Cost Peptide is an independent evidence-lifecycle digest that audits what peptide claims cost to prove; it is neither a store nor medical advice.